National Health Investors (NYSE:NHI) Shares Gap Up – Should You Buy?

National Health Investors, Inc. (NYSE:NHI)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $73.03, but opened at $76.00. National Health Investors shares last traded at $75.4150, with a volume of 102,572 shares.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on NHI shares. Weiss Ratings cut shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. Truist Financial reduced their price objective on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research note on Friday, June 12th. BMO Capital Markets decreased their target price on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research report on Monday, June 15th. Wells Fargo & Company lowered their target price on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research note on Monday, June 1st. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $94.00 price target on shares of National Health Investors in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $84.57.

National Health Investors Stock Performance

The business has a 50 day simple moving average of $75.42 and a 200 day simple moving average of $79.70. The company has a quick ratio of 8.20, a current ratio of 8.20 and a debt-to-equity ratio of 0.83. The company has a market capitalization of $3.68 billion, a PE ratio of 24.57, a PEG ratio of 3.81 and a beta of 0.52.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.39). National Health Investors had a return on equity of 9.82% and a net margin of 36.86%.The business had revenue of $115.13 million for the quarter, compared to analysts’ expectations of $70.22 million. During the same quarter in the previous year, the firm posted $1.15 EPS. National Health Investors’s revenue was up 28.9% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Equities research analysts predict that National Health Investors, Inc. will post 4.93 EPS for the current fiscal year.

National Health Investors Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Tuesday, June 30th will be paid a $0.92 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $3.68 dividend on an annualized basis and a yield of 4.8%. National Health Investors’s dividend payout ratio (DPR) is 118.71%.

Insider Activity at National Health Investors

In related news, Director Robert A. Mccabe, Jr. purchased 890 shares of the business’s stock in a transaction on Monday, June 15th. The shares were acquired at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the purchase, the director owned 44,159 shares of the company’s stock, valued at $3,163,992.35. This trade represents a 2.06% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of the firm’s stock in a transaction on Friday, June 5th. The stock was bought at an average cost of $68.84 per share, with a total value of $103,260.00. Following the acquisition, the chief executive officer owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. The trade was a 1.14% increase in their position. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is currently owned by insiders.

Hedge Funds Weigh In On National Health Investors

Hedge funds have recently made changes to their positions in the company. International Assets Investment Management LLC acquired a new stake in National Health Investors during the 4th quarter worth about $27,000. EverSource Wealth Advisors LLC grew its stake in National Health Investors by 244.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after purchasing an additional 288 shares during the last quarter. Garton & Associates Financial Advisors LLC acquired a new position in shares of National Health Investors in the fourth quarter valued at about $33,000. GAMMA Investing LLC increased its holdings in shares of National Health Investors by 41.8% in the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 136 shares during the period. Finally, Key Capital Management INC purchased a new position in shares of National Health Investors in the fourth quarter worth about $47,000. 62.51% of the stock is owned by institutional investors and hedge funds.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.